Combining AI imaging and spectral chips to create a smart medical platform

After the epidemic eases, AI will become the next major factor affecting the medical industry. Due to the vigorous development of science and technology, the quality of medical care has been greatly improved, and the average life expectancy of human beings has been extended from 40 years in the 19th century to 80 years in the 21st century. Aging has become one of the most important issues in the world and is also a severe challenge facing the medical industry. Kaohsiung Xiaogang Hospital will work with Yiyang Technology, Global Life Sciences, and Shenguang Chip to develop a product that combines AI imaging and physiological data. The all-round medical detection assistance system is expected to bring global benefits to smart healthcare, telemedicine, emergency and critical care, long-term care, etc.

Yiyang Technology has long been planning the AI ​​medical market and is a leading manufacturer of medical imaging computing in China. It has also cooperated with international giants such as Intel and NVidia to develop medical AI technology platforms. Its MD116E portable auxiliary system has been used in many domestic and foreign Adopted by benchmark hospitals. Yiyang Global General Manager Zhuang Fujun explained today (30th) that Yiyang has a strong technical background in computers and communications. In recent years, the results of its investment in AI medical care have also been deeply recognized by the international market. This cooperation is also implemented in the field of AI medical care. The diversified growth operation strategy is expected to develop a more comprehensive medical assistance system by adding the collection of physiological data.

The spectral chip, the result of many years of research by Professor Ke Zhenghao, the founder of SGIC, will play an important role in collecting physiological data in this cooperation project; the rapid screening quantitative system developed during the epidemic has demonstrated the application of spectral chips in medical testing. The huge potential of the market, through the miniature spectrometer series equipped with spectral chips, can quickly, conveniently and locally obtain laboratory-like accurate test results, which will realize the vision of decentralized testing. We hope that this collaboration will become an important milestone in the transition from the GPU generation to the SPU generation.

Director Hung Chih-hsing of Kaohsiung Siaogang Hospital said that in recent years, Siaogang Hospital has invested a lot of resources in building a smart hospital. This time, it is able to combine the strength of the industry to build a smart system that combines imaging data and physiological data, and through the use of AI, develop targeted An auxiliary system that provides substantial help in clinical practice can not only save resources consumed by doctors in seeing patients and accelerate the learning of new medical staff, but also provide the public with more convenient and reliable medical services, thus killing two birds with one stone.

The signing ceremony of the memorandum of cooperation between the four parties was also attended by Edward, President of the American Chamber of Commerce in Southern Taiwan, and other important figures from home and abroad. They all look forward to the results of this cooperation, which will become a highlight of Taiwan's medical innovation. It can also be promoted to the international market, creating higher market benefits, benefiting the healthy lives of all mankind, and writing another glorious chapter of "Taiwan's experience, benefiting the world."